Research ExplorerPublicationsTechniques for experimental heterotopic and orthotopic trach...

Techniques for experimental heterotopic and orthotopic tracheal transplantations - When to use which model?

Standard

Techniques for experimental heterotopic and orthotopic tracheal transplantations - When to use which model? / Deuse, Tobias; Schrepfer, Sonja; Reichenspurner, Hermann; Hoyt, Grant; Fischbein, Michael P; Robbins, Robert C; Pelletier, Marc P.

In: TRANSPL IMMUNOL, Vol. 17, No. 4, 06.2007, p. 255-261.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Deuse, T, Schrepfer, S, Reichenspurner, H, Hoyt, G, Fischbein, MP, Robbins, RC & Pelletier, MP 2007, 'Techniques for experimental heterotopic and orthotopic tracheal transplantations - When to use which model?', TRANSPL IMMUNOL, vol. 17, no. 4, pp. 255-261. https://doi.org/10.1016/j.trim.2007.01.009

APA

Deuse, T., Schrepfer, S., Reichenspurner, H., Hoyt, G., Fischbein, M. P., Robbins, R. C., & Pelletier, M. P. (2007). Techniques for experimental heterotopic and orthotopic tracheal transplantations - When to use which model? TRANSPL IMMUNOL, 17(4), 255-261. https://doi.org/10.1016/j.trim.2007.01.009

Vancouver

Deuse T, Schrepfer S, Reichenspurner H, Hoyt G, Fischbein MP, Robbins RC et al. Techniques for experimental heterotopic and orthotopic tracheal transplantations - When to use which model? TRANSPL IMMUNOL. 2007 Jun;17(4):255-261. https://doi.org/10.1016/j.trim.2007.01.009

Bibtex

@article{1da0d193f3c44c4f823fbd89751520a6,
title = "Techniques for experimental heterotopic and orthotopic tracheal transplantations - When to use which model?",
abstract = "BACKGROUND: Different animal models have been developed to study the pathogenesis and treatment of obliterative airway disease (OAD). Here we describe the techniques of heterotopic and orthotopic tracheal transplantations in the rat, comparing the kinetics of systemic host immune response and of histopathologic OAD development.METHODS: Heterotopic and orthotopic tracheal transplantations were performed in both allogeneic (Brown Norway-to-Lewis) and syngeneic (Lewis-to-Lewis) models. Grafts were harvested after 7, 30, and 60 days post-transplant for histologic evaluation and analysis of host cellular and humoral response.RESULTS: Syngeneic tracheal grafts did not develop luminal obliteration and were morphologically indistinguishable from native tracheas. In heterotopic allografts, airway epithelium was rapidly destroyed and OAD progressed with complete luminal occlusion by 30 days. Orthotopic allografts showed enhanced early infiltration (1298+/-45 vs. 674+/-75 cells/high power field, p<0.001) with concomitant greater day 7 luminal narrowing (45+/-6% vs. 14+/-3%, p<0.001). In this model, donor-type BN epithelium (62+/-17%, 21+/-19%, and 1+/-1% on days 7, 30, and 60) was gradually replaced by recipient-type epithelial cells (2+/-4%, 70+/-22%, and 98+/-2%). OAD developed with circular orientation of cells and connective tissue fibers to 45+/-6% obliteration by day 60. Cellular host response, as determined by IFN-gamma-ELISPOT assay (548+/-132 vs. 402+/-197 spots, p=0.046) and anti-donor alloreactive IgM antibody production (2827+/-148 vs. 1565+/-393 mean channel fluorescence, p<0.001) were significantly stronger in rats bearing orthotopic vs. heterotopic allografts.CONCLUSIONS: The orthotopic tracheal transplantation model may be more representative of OAD found in human lung transplant recipients and we therefore encourage the wider use of this model.",
keywords = "Animals, Antibody Formation, Disease Models, Animal, Epithelial Cells/immunology, Male, Organ Transplantation/methods, Pulmonary Disease, Chronic Obstructive/immunology, Rats, Rats, Inbred Strains, Trachea/immunology, Transplants",
author = "Tobias Deuse and Sonja Schrepfer and Hermann Reichenspurner and Grant Hoyt and Fischbein, {Michael P} and Robbins, {Robert C} and Pelletier, {Marc P}",
year = "2007",
month = jun,
doi = "10.1016/j.trim.2007.01.009",
language = "English",
volume = "17",
pages = "255--261",
journal = "TRANSPL IMMUNOL",
issn = "0966-3274",
publisher = "Elsevier",
number = "4",

}

RIS

TY - JOUR

T1 - Techniques for experimental heterotopic and orthotopic tracheal transplantations - When to use which model?

AU - Deuse, Tobias

AU - Schrepfer, Sonja

AU - Reichenspurner, Hermann

AU - Hoyt, Grant

AU - Fischbein, Michael P

AU - Robbins, Robert C

AU - Pelletier, Marc P

PY - 2007/6

Y1 - 2007/6

N2 - BACKGROUND: Different animal models have been developed to study the pathogenesis and treatment of obliterative airway disease (OAD). Here we describe the techniques of heterotopic and orthotopic tracheal transplantations in the rat, comparing the kinetics of systemic host immune response and of histopathologic OAD development.METHODS: Heterotopic and orthotopic tracheal transplantations were performed in both allogeneic (Brown Norway-to-Lewis) and syngeneic (Lewis-to-Lewis) models. Grafts were harvested after 7, 30, and 60 days post-transplant for histologic evaluation and analysis of host cellular and humoral response.RESULTS: Syngeneic tracheal grafts did not develop luminal obliteration and were morphologically indistinguishable from native tracheas. In heterotopic allografts, airway epithelium was rapidly destroyed and OAD progressed with complete luminal occlusion by 30 days. Orthotopic allografts showed enhanced early infiltration (1298+/-45 vs. 674+/-75 cells/high power field, p<0.001) with concomitant greater day 7 luminal narrowing (45+/-6% vs. 14+/-3%, p<0.001). In this model, donor-type BN epithelium (62+/-17%, 21+/-19%, and 1+/-1% on days 7, 30, and 60) was gradually replaced by recipient-type epithelial cells (2+/-4%, 70+/-22%, and 98+/-2%). OAD developed with circular orientation of cells and connective tissue fibers to 45+/-6% obliteration by day 60. Cellular host response, as determined by IFN-gamma-ELISPOT assay (548+/-132 vs. 402+/-197 spots, p=0.046) and anti-donor alloreactive IgM antibody production (2827+/-148 vs. 1565+/-393 mean channel fluorescence, p<0.001) were significantly stronger in rats bearing orthotopic vs. heterotopic allografts.CONCLUSIONS: The orthotopic tracheal transplantation model may be more representative of OAD found in human lung transplant recipients and we therefore encourage the wider use of this model.

AB - BACKGROUND: Different animal models have been developed to study the pathogenesis and treatment of obliterative airway disease (OAD). Here we describe the techniques of heterotopic and orthotopic tracheal transplantations in the rat, comparing the kinetics of systemic host immune response and of histopathologic OAD development.METHODS: Heterotopic and orthotopic tracheal transplantations were performed in both allogeneic (Brown Norway-to-Lewis) and syngeneic (Lewis-to-Lewis) models. Grafts were harvested after 7, 30, and 60 days post-transplant for histologic evaluation and analysis of host cellular and humoral response.RESULTS: Syngeneic tracheal grafts did not develop luminal obliteration and were morphologically indistinguishable from native tracheas. In heterotopic allografts, airway epithelium was rapidly destroyed and OAD progressed with complete luminal occlusion by 30 days. Orthotopic allografts showed enhanced early infiltration (1298+/-45 vs. 674+/-75 cells/high power field, p<0.001) with concomitant greater day 7 luminal narrowing (45+/-6% vs. 14+/-3%, p<0.001). In this model, donor-type BN epithelium (62+/-17%, 21+/-19%, and 1+/-1% on days 7, 30, and 60) was gradually replaced by recipient-type epithelial cells (2+/-4%, 70+/-22%, and 98+/-2%). OAD developed with circular orientation of cells and connective tissue fibers to 45+/-6% obliteration by day 60. Cellular host response, as determined by IFN-gamma-ELISPOT assay (548+/-132 vs. 402+/-197 spots, p=0.046) and anti-donor alloreactive IgM antibody production (2827+/-148 vs. 1565+/-393 mean channel fluorescence, p<0.001) were significantly stronger in rats bearing orthotopic vs. heterotopic allografts.CONCLUSIONS: The orthotopic tracheal transplantation model may be more representative of OAD found in human lung transplant recipients and we therefore encourage the wider use of this model.

KW - Animals

KW - Antibody Formation

KW - Disease Models, Animal

KW - Epithelial Cells/immunology

KW - Male

KW - Organ Transplantation/methods

KW - Pulmonary Disease, Chronic Obstructive/immunology

KW - Rats

KW - Rats, Inbred Strains

KW - Trachea/immunology

KW - Transplants

U2 - 10.1016/j.trim.2007.01.009

DO - 10.1016/j.trim.2007.01.009

M3 - SCORING: Journal article

C2 - 17493528

VL - 17

SP - 255

EP - 261

JO - TRANSPL IMMUNOL

JF - TRANSPL IMMUNOL

SN - 0966-3274

IS - 4

ER -